nodes	percent_of_prediction	percent_of_DWPC	metapath
Fingolimod—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0539	0.0986	CbGbCtD
Fingolimod—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0398	0.0729	CbGbCtD
Fingolimod—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.0375	0.0686	CbGbCtD
Fingolimod—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.0375	0.0686	CbGbCtD
Fingolimod—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0339	0.062	CbGbCtD
Fingolimod—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0339	0.062	CbGbCtD
Fingolimod—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0292	0.0535	CbGbCtD
Fingolimod—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0284	0.052	CbGbCtD
Fingolimod—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.0257	0.047	CbGbCtD
Fingolimod—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.0257	0.047	CbGbCtD
Fingolimod—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.0253	0.0464	CbGbCtD
Fingolimod—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.0238	0.0436	CbGbCtD
Fingolimod—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.0238	0.0436	CbGbCtD
Fingolimod—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.0215	0.0394	CbGbCtD
Fingolimod—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.0215	0.0394	CbGbCtD
Fingolimod—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.0186	0.034	CbGbCtD
Fingolimod—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.018	0.033	CbGbCtD
Fingolimod—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.0163	0.0299	CbGbCtD
Fingolimod—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.0163	0.0299	CbGbCtD
Fingolimod—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.0156	0.0286	CbGbCtD
Fingolimod—S1PR1—endothelium—acquired immunodeficiency syndrome	0.00731	0.0565	CbGeAlD
Fingolimod—S1PR5—skin of body—acquired immunodeficiency syndrome	0.00426	0.0329	CbGeAlD
Fingolimod—S1PR4—lymphoid tissue—acquired immunodeficiency syndrome	0.0041	0.0317	CbGeAlD
Fingolimod—S1PR4—blood—acquired immunodeficiency syndrome	0.00386	0.0299	CbGeAlD
Fingolimod—S1PR4—bone marrow—acquired immunodeficiency syndrome	0.00374	0.0289	CbGeAlD
Fingolimod—SPHK1—retina—acquired immunodeficiency syndrome	0.00352	0.0272	CbGeAlD
Fingolimod—S1PR5—lymphoid tissue—acquired immunodeficiency syndrome	0.00345	0.0267	CbGeAlD
Fingolimod—S1PR4—lung—acquired immunodeficiency syndrome	0.00339	0.0262	CbGeAlD
Fingolimod—S1PR5—blood—acquired immunodeficiency syndrome	0.00324	0.0251	CbGeAlD
Fingolimod—CYP4F2—digestive system—acquired immunodeficiency syndrome	0.00319	0.0247	CbGeAlD
Fingolimod—SPHK1—skin of body—acquired immunodeficiency syndrome	0.00309	0.0239	CbGeAlD
Fingolimod—CYP4F2—blood—acquired immunodeficiency syndrome	0.00304	0.0235	CbGeAlD
Fingolimod—CYP4F2—bone marrow—acquired immunodeficiency syndrome	0.00294	0.0227	CbGeAlD
Fingolimod—S1PR3—lymphoid tissue—acquired immunodeficiency syndrome	0.00287	0.0221	CbGeAlD
Fingolimod—CYP4F2—vagina—acquired immunodeficiency syndrome	0.00282	0.0218	CbGeAlD
Fingolimod—S1PR5—nervous system—acquired immunodeficiency syndrome	0.00263	0.0204	CbGeAlD
Fingolimod—S1PR5—central nervous system—acquired immunodeficiency syndrome	0.00254	0.0196	CbGeAlD
Fingolimod—S1PR1—lymphoid tissue—acquired immunodeficiency syndrome	0.00253	0.0195	CbGeAlD
Fingolimod—S1PR1—blood—acquired immunodeficiency syndrome	0.00238	0.0184	CbGeAlD
Fingolimod—CYP4F12—digestive system—acquired immunodeficiency syndrome	0.00237	0.0183	CbGeAlD
Fingolimod—S1PR3—lung—acquired immunodeficiency syndrome	0.00236	0.0183	CbGeAlD
Fingolimod—SPHK1—blood—acquired immunodeficiency syndrome	0.00235	0.0182	CbGeAlD
Fingolimod—S1PR4—lymph node—acquired immunodeficiency syndrome	0.00232	0.0179	CbGeAlD
Fingolimod—S1PR1—spinal cord—acquired immunodeficiency syndrome	0.00229	0.0177	CbGeAlD
Fingolimod—CYP4F12—blood—acquired immunodeficiency syndrome	0.00226	0.0175	CbGeAlD
Fingolimod—S1PR1—vagina—acquired immunodeficiency syndrome	0.0022	0.017	CbGeAlD
Fingolimod—S1PR3—nervous system—acquired immunodeficiency syndrome	0.00219	0.0169	CbGeAlD
Fingolimod—CYP4F12—bone marrow—acquired immunodeficiency syndrome	0.00219	0.0169	CbGeAlD
Fingolimod—SPHK1—vagina—acquired immunodeficiency syndrome	0.00218	0.0169	CbGeAlD
Fingolimod—CYP4F12—spinal cord—acquired immunodeficiency syndrome	0.00218	0.0168	CbGeAlD
Fingolimod—S1PR3—central nervous system—acquired immunodeficiency syndrome	0.00211	0.0163	CbGeAlD
Fingolimod—CYP4F12—vagina—acquired immunodeficiency syndrome	0.00209	0.0162	CbGeAlD
Fingolimod—S1PR1—lung—acquired immunodeficiency syndrome	0.00208	0.0161	CbGeAlD
Fingolimod—SPHK1—lung—acquired immunodeficiency syndrome	0.00206	0.0159	CbGeAlD
Fingolimod—S1PR5—brain—acquired immunodeficiency syndrome	0.00201	0.0156	CbGeAlD
Fingolimod—CYP4F12—lung—acquired immunodeficiency syndrome	0.00198	0.0153	CbGeAlD
Fingolimod—S1PR5—lymph node—acquired immunodeficiency syndrome	0.00195	0.015	CbGeAlD
Fingolimod—S1PR1—nervous system—acquired immunodeficiency syndrome	0.00193	0.0149	CbGeAlD
Fingolimod—SPHK1—nervous system—acquired immunodeficiency syndrome	0.00191	0.0148	CbGeAlD
Fingolimod—S1PR1—central nervous system—acquired immunodeficiency syndrome	0.00186	0.0144	CbGeAlD
Fingolimod—S1PR3—brain—acquired immunodeficiency syndrome	0.00167	0.0129	CbGeAlD
Fingolimod—S1PR3—lymph node—acquired immunodeficiency syndrome	0.00162	0.0125	CbGeAlD
Fingolimod—S1PR1—brain—acquired immunodeficiency syndrome	0.00148	0.0114	CbGeAlD
Fingolimod—SPHK1—brain—acquired immunodeficiency syndrome	0.00146	0.0113	CbGeAlD
Fingolimod—S1PR1—lymph node—acquired immunodeficiency syndrome	0.00143	0.011	CbGeAlD
Fingolimod—SPHK1—lymph node—acquired immunodeficiency syndrome	0.00141	0.0109	CbGeAlD
Fingolimod—CYP4F12—brain—acquired immunodeficiency syndrome	0.0014	0.0108	CbGeAlD
Fingolimod—CYP4F12—lymph node—acquired immunodeficiency syndrome	0.00135	0.0105	CbGeAlD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00115	0.0104	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00108	0.00979	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of proteins—ENPEP—acquired immunodeficiency syndrome	0.00108	0.00977	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—ACKR1—acquired immunodeficiency syndrome	0.00104	0.00946	CbGpPWpGaD
Fingolimod—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.00104	0.00804	CbGeAlD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00104	0.00942	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.00104	0.00942	CbGpPWpGaD
Fingolimod—S1PR1—GPCRs, Other—CCR5—acquired immunodeficiency syndrome	0.00101	0.00915	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CCL4—acquired immunodeficiency syndrome	0.000944	0.00856	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.00091	0.00824	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000876	0.00793	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000876	0.00793	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000839	0.00761	CbGpPWpGaD
Fingolimod—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000837	0.00647	CbGeAlD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000834	0.00756	CbGpPWpGaD
Fingolimod—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.000824	0.00637	CbGeAlD
Fingolimod—S1PR4—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000823	0.00745	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000808	0.00732	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000808	0.00732	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—ACKR1—acquired immunodeficiency syndrome	0.000795	0.0072	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000792	0.00717	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000792	0.00717	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.000789	0.00715	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.000789	0.00715	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.00077	0.00698	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00076	0.00688	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00076	0.00688	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00076	0.00688	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00076	0.00688	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000742	0.00672	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000742	0.00672	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000738	0.00669	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—CCR2—acquired immunodeficiency syndrome	0.000734	0.00665	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CCL4—acquired immunodeficiency syndrome	0.000719	0.00651	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—AGPS—acquired immunodeficiency syndrome	0.000716	0.00649	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00071	0.00644	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.00071	0.00644	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—CXCL12—acquired immunodeficiency syndrome	0.00069	0.00625	CbGpPWpGaD
Fingolimod—S1PR1—G alpha (i) signalling events—CXCR4—acquired immunodeficiency syndrome	0.00069	0.00625	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CCL3L1—acquired immunodeficiency syndrome	0.000673	0.0061	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000667	0.00605	CbGpPWpGaD
Fingolimod—SPHK1—VEGFR2 mediated cell proliferation—IL6—acquired immunodeficiency syndrome	0.000667	0.00605	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CCL3—acquired immunodeficiency syndrome	0.000645	0.00584	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000642	0.00582	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000642	0.00582	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000627	0.00569	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000627	0.00569	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000604	0.00547	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000604	0.00547	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000604	0.00547	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000604	0.00547	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.0006	0.00544	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CCR2—acquired immunodeficiency syndrome	0.000583	0.00529	CbGpPWpGaD
Fingolimod—S1PR3—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000578	0.00524	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000578	0.00524	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000562	0.00509	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CXCR4—acquired immunodeficiency syndrome	0.000548	0.00497	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CXCL12—acquired immunodeficiency syndrome	0.000548	0.00497	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000541	0.0049	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000541	0.0049	CbGpPWpGaD
Fingolimod—S1PR4—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000541	0.0049	CbGpPWpGaD
Fingolimod—Bronchitis—Delavirdine—acquired immunodeficiency syndrome	0.000525	0.00245	CcSEcCtD
Fingolimod—S1PR1—G alpha (i) signalling events—CCL5—acquired immunodeficiency syndrome	0.000525	0.00475	CbGpPWpGaD
Fingolimod—Mental disorder—Stavudine—acquired immunodeficiency syndrome	0.000524	0.00245	CcSEcCtD
Fingolimod—Skin disorder—Amprenavir—acquired immunodeficiency syndrome	0.000521	0.00244	CcSEcCtD
Fingolimod—S1PR3—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000521	0.00472	CbGpPWpGaD
Fingolimod—S1PR5—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000521	0.00472	CbGpPWpGaD
Fingolimod—Alopecia—Abacavir—acquired immunodeficiency syndrome	0.00052	0.00243	CcSEcCtD
Fingolimod—Liver function test abnormal—Saquinavir—acquired immunodeficiency syndrome	0.000519	0.00243	CcSEcCtD
Fingolimod—Pneumonia—Efavirenz—acquired immunodeficiency syndrome	0.000512	0.00239	CcSEcCtD
Fingolimod—Connective tissue disorder—Zidovudine—acquired immunodeficiency syndrome	0.000511	0.00239	CcSEcCtD
Fingolimod—Infestation—Efavirenz—acquired immunodeficiency syndrome	0.000509	0.00238	CcSEcCtD
Fingolimod—Infestation NOS—Efavirenz—acquired immunodeficiency syndrome	0.000509	0.00238	CcSEcCtD
Fingolimod—S1PR4—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000508	0.0046	CbGpPWpGaD
Fingolimod—Depression—Efavirenz—acquired immunodeficiency syndrome	0.000507	0.00237	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Saquinavir—acquired immunodeficiency syndrome	0.000506	0.00237	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—TAT—acquired immunodeficiency syndrome	0.000506	0.00458	CbGpPWpGaD
Fingolimod—Sinusitis—Indinavir—acquired immunodeficiency syndrome	0.000505	0.00236	CcSEcCtD
Fingolimod—Back pain—Nelfinavir—acquired immunodeficiency syndrome	0.000505	0.00236	CcSEcCtD
Fingolimod—Influenza—Ritonavir—acquired immunodeficiency syndrome	0.000505	0.00236	CcSEcCtD
Fingolimod—Back pain—Stavudine—acquired immunodeficiency syndrome	0.000503	0.00235	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Saquinavir—acquired immunodeficiency syndrome	0.000496	0.00232	CcSEcCtD
Fingolimod—Liver function test abnormal—Lamivudine—acquired immunodeficiency syndrome	0.000495	0.00231	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—CCL3—acquired immunodeficiency syndrome	0.000491	0.00445	CbGpPWpGaD
Fingolimod—Pneumonia—Delavirdine—acquired immunodeficiency syndrome	0.000489	0.00229	CcSEcCtD
Fingolimod—S1PR5—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000489	0.00443	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000489	0.00443	CbGpPWpGaD
Fingolimod—Infection—Didanosine—acquired immunodeficiency syndrome	0.000486	0.00227	CcSEcCtD
Fingolimod—Influenza—Saquinavir—acquired immunodeficiency syndrome	0.000486	0.00227	CcSEcCtD
Fingolimod—Bronchitis—Ritonavir—acquired immunodeficiency syndrome	0.000485	0.00227	CcSEcCtD
Fingolimod—Aspartate aminotransferase increased—Lamivudine—acquired immunodeficiency syndrome	0.000483	0.00226	CcSEcCtD
Fingolimod—Cardiac disorder—Zidovudine—acquired immunodeficiency syndrome	0.000482	0.00225	CcSEcCtD
Fingolimod—Paraesthesia—Amprenavir—acquired immunodeficiency syndrome	0.000482	0.00225	CcSEcCtD
Fingolimod—S1PR4—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000478	0.00433	CbGpPWpGaD
Fingolimod—S1PR4—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000478	0.00433	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000477	0.00433	CbGpPWpGaD
Fingolimod—Sinusitis—Efavirenz—acquired immunodeficiency syndrome	0.000477	0.00223	CcSEcCtD
Fingolimod—Connective tissue disorder—Indinavir—acquired immunodeficiency syndrome	0.000475	0.00222	CcSEcCtD
Fingolimod—Alanine aminotransferase increased—Lamivudine—acquired immunodeficiency syndrome	0.000473	0.00221	CcSEcCtD
Fingolimod—S1PR1—G alpha (i) signalling events—CCR5—acquired immunodeficiency syndrome	0.000473	0.00428	CbGpPWpGaD
Fingolimod—Mediastinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000468	0.00219	CcSEcCtD
Fingolimod—Leukopenia—Nelfinavir—acquired immunodeficiency syndrome	0.000467	0.00218	CcSEcCtD
Fingolimod—Bronchitis—Saquinavir—acquired immunodeficiency syndrome	0.000467	0.00218	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000467	0.00423	CbGpPWpGaD
Fingolimod—Leukopenia—Stavudine—acquired immunodeficiency syndrome	0.000466	0.00218	CcSEcCtD
Fingolimod—Influenza—Lamivudine—acquired immunodeficiency syndrome	0.000463	0.00217	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Amprenavir—acquired immunodeficiency syndrome	0.000463	0.00217	CcSEcCtD
Fingolimod—Fatigue—Amprenavir—acquired immunodeficiency syndrome	0.000463	0.00216	CcSEcCtD
Fingolimod—S1PR3—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00046	0.00417	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00046	0.00417	CbGpPWpGaD
Fingolimod—S1PR3—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.00046	0.00417	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.00046	0.00417	CbGpPWpGaD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000459	0.00416	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000459	0.00416	CbGpPWpGaD
Fingolimod—Leukopenia—Abacavir—acquired immunodeficiency syndrome	0.000459	0.00214	CcSEcCtD
Fingolimod—Weight decreased—Ritonavir—acquired immunodeficiency syndrome	0.000457	0.00213	CcSEcCtD
Fingolimod—Sinusitis—Delavirdine—acquired immunodeficiency syndrome	0.000457	0.00213	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Nevirapine—acquired immunodeficiency syndrome	0.000456	0.00213	CcSEcCtD
Fingolimod—Mental disorder—Zidovudine—acquired immunodeficiency syndrome	0.000455	0.00213	CcSEcCtD
Fingolimod—S1PR4—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000455	0.00412	CbGpPWpGaD
Fingolimod—Cough—Stavudine—acquired immunodeficiency syndrome	0.000454	0.00212	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000449	0.00407	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000449	0.00407	CbGpPWpGaD
Fingolimod—Depression—Ritonavir—acquired immunodeficiency syndrome	0.000449	0.0021	CcSEcCtD
Fingolimod—Connective tissue disorder—Efavirenz—acquired immunodeficiency syndrome	0.000449	0.0021	CcSEcCtD
Fingolimod—Cough—Abacavir—acquired immunodeficiency syndrome	0.000447	0.00209	CcSEcCtD
Fingolimod—Bronchitis—Lamivudine—acquired immunodeficiency syndrome	0.000446	0.00208	CcSEcCtD
Fingolimod—Bradycardia—Delavirdine—acquired immunodeficiency syndrome	0.000445	0.00208	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—CCR2—acquired immunodeficiency syndrome	0.000444	0.00402	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Nelfinavir—acquired immunodeficiency syndrome	0.000441	0.00206	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Stavudine—acquired immunodeficiency syndrome	0.00044	0.00206	CcSEcCtD
Fingolimod—Weight decreased—Saquinavir—acquired immunodeficiency syndrome	0.000439	0.00205	CcSEcCtD
Fingolimod—Paraesthesia—Didanosine—acquired immunodeficiency syndrome	0.000439	0.00205	CcSEcCtD
Fingolimod—S1PR3—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000438	0.00397	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000438	0.00397	CbGpPWpGaD
Fingolimod—Back pain—Zidovudine—acquired immunodeficiency syndrome	0.000438	0.00205	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—TAT—acquired immunodeficiency syndrome	0.000437	0.00396	CbGpPWpGaD
Fingolimod—Pneumonia—Saquinavir—acquired immunodeficiency syndrome	0.000436	0.00204	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Abacavir—acquired immunodeficiency syndrome	0.000433	0.00203	CcSEcCtD
Fingolimod—Infestation—Saquinavir—acquired immunodeficiency syndrome	0.000433	0.00202	CcSEcCtD
Fingolimod—Infestation NOS—Saquinavir—acquired immunodeficiency syndrome	0.000433	0.00202	CcSEcCtD
Fingolimod—Depression—Saquinavir—acquired immunodeficiency syndrome	0.000432	0.00202	CcSEcCtD
Fingolimod—Nervous system disorder—Nevirapine—acquired immunodeficiency syndrome	0.000431	0.00202	CcSEcCtD
Fingolimod—CYP4F12—Metabolism—AGPS—acquired immunodeficiency syndrome	0.00043	0.0039	CbGpPWpGaD
Fingolimod—S1PR4—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.00043	0.0039	CbGpPWpGaD
Fingolimod—Skin disorder—Nevirapine—acquired immunodeficiency syndrome	0.000427	0.002	CcSEcCtD
Fingolimod—Alopecia—Indinavir—acquired immunodeficiency syndrome	0.000427	0.002	CcSEcCtD
Fingolimod—Eye disorder—Efavirenz—acquired immunodeficiency syndrome	0.000427	0.00199	CcSEcCtD
Fingolimod—Cardiac disorder—Efavirenz—acquired immunodeficiency syndrome	0.000424	0.00198	CcSEcCtD
Fingolimod—Sinusitis—Ritonavir—acquired immunodeficiency syndrome	0.000422	0.00197	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000422	0.00382	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CXCL12—acquired immunodeficiency syndrome	0.000418	0.00378	CbGpPWpGaD
Fingolimod—S1PR1—GPCR ligand binding—CXCR4—acquired immunodeficiency syndrome	0.000418	0.00378	CbGpPWpGaD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CCL5—acquired immunodeficiency syndrome	0.000417	0.00378	CbGpPWpGaD
Fingolimod—Nervous system disorder—Stavudine—acquired immunodeficiency syndrome	0.000417	0.00195	CcSEcCtD
Fingolimod—Infection—Abacavir—acquired immunodeficiency syndrome	0.000416	0.00194	CcSEcCtD
Fingolimod—Angiopathy—Efavirenz—acquired immunodeficiency syndrome	0.000414	0.00194	CcSEcCtD
Fingolimod—S1PR3—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000414	0.00375	CbGpPWpGaD
Fingolimod—S1PR5—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000414	0.00375	CbGpPWpGaD
Fingolimod—Skin disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000414	0.00193	CcSEcCtD
Fingolimod—Skin disorder—Stavudine—acquired immunodeficiency syndrome	0.000413	0.00193	CcSEcCtD
Fingolimod—Depression—Lamivudine—acquired immunodeficiency syndrome	0.000412	0.00193	CcSEcCtD
Fingolimod—Mediastinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.000411	0.00192	CcSEcCtD
Fingolimod—Nervous system disorder—Abacavir—acquired immunodeficiency syndrome	0.00041	0.00192	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—ACKR1—acquired immunodeficiency syndrome	0.000408	0.0037	CbGpPWpGaD
Fingolimod—Back pain—Indinavir—acquired immunodeficiency syndrome	0.000407	0.0019	CcSEcCtD
Fingolimod—Skin disorder—Abacavir—acquired immunodeficiency syndrome	0.000406	0.0019	CcSEcCtD
Fingolimod—Sinusitis—Saquinavir—acquired immunodeficiency syndrome	0.000406	0.0019	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000406	0.00368	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000406	0.00368	CbGpPWpGaD
Fingolimod—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000405	0.00313	CbGeAlD
Fingolimod—Leukopenia—Zidovudine—acquired immunodeficiency syndrome	0.000405	0.00189	CcSEcCtD
Fingolimod—Alopecia—Efavirenz—acquired immunodeficiency syndrome	0.000403	0.00189	CcSEcCtD
Fingolimod—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.0004	0.00309	CbGeAlD
Fingolimod—S1PR1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000398	0.0036	CbGpPWpGaD
Fingolimod—Connective tissue disorder—Ritonavir—acquired immunodeficiency syndrome	0.000397	0.00186	CcSEcCtD
Fingolimod—Vision blurred—Indinavir—acquired immunodeficiency syndrome	0.000396	0.00185	CcSEcCtD
Fingolimod—Paraesthesia—Nevirapine—acquired immunodeficiency syndrome	0.000395	0.00185	CcSEcCtD
Fingolimod—Cough—Zidovudine—acquired immunodeficiency syndrome	0.000395	0.00184	CcSEcCtD
Fingolimod—Hypotension—Abacavir—acquired immunodeficiency syndrome	0.000391	0.00183	CcSEcCtD
Fingolimod—Sinusitis—Lamivudine—acquired immunodeficiency syndrome	0.000388	0.00181	CcSEcCtD
Fingolimod—Alopecia—Delavirdine—acquired immunodeficiency syndrome	0.000386	0.0018	CcSEcCtD
Fingolimod—Asthenia—Amprenavir—acquired immunodeficiency syndrome	0.000385	0.0018	CcSEcCtD
Fingolimod—Back pain—Efavirenz—acquired immunodeficiency syndrome	0.000384	0.0018	CcSEcCtD
Fingolimod—Paraesthesia—Nelfinavir—acquired immunodeficiency syndrome	0.000383	0.00179	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Zidovudine—acquired immunodeficiency syndrome	0.000382	0.00179	CcSEcCtD
Fingolimod—Connective tissue disorder—Saquinavir—acquired immunodeficiency syndrome	0.000382	0.00179	CcSEcCtD
Fingolimod—Paraesthesia—Stavudine—acquired immunodeficiency syndrome	0.000381	0.00178	CcSEcCtD
Fingolimod—CYP2E1—blood—acquired immunodeficiency syndrome	0.000381	0.00295	CbGeAlD
Fingolimod—Dyspnoea—Nelfinavir—acquired immunodeficiency syndrome	0.00038	0.00178	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Nevirapine—acquired immunodeficiency syndrome	0.00038	0.00178	CcSEcCtD
Fingolimod—Pruritus—Amprenavir—acquired immunodeficiency syndrome	0.00038	0.00177	CcSEcCtD
Fingolimod—Fatigue—Nevirapine—acquired immunodeficiency syndrome	0.000379	0.00177	CcSEcCtD
Fingolimod—Eye disorder—Ritonavir—acquired immunodeficiency syndrome	0.000378	0.00176	CcSEcCtD
Fingolimod—S1PR1—Class A/1 (Rhodopsin-like receptors)—CCR5—acquired immunodeficiency syndrome	0.000376	0.00341	CbGpPWpGaD
Fingolimod—Paraesthesia—Abacavir—acquired immunodeficiency syndrome	0.000376	0.00176	CcSEcCtD
Fingolimod—SPHK1—Metabolism—TAT—acquired immunodeficiency syndrome	0.000375	0.0034	CbGpPWpGaD
Fingolimod—Cardiac disorder—Ritonavir—acquired immunodeficiency syndrome	0.000375	0.00175	CcSEcCtD
Fingolimod—Vision blurred—Efavirenz—acquired immunodeficiency syndrome	0.000375	0.00175	CcSEcCtD
Fingolimod—Dyspnoea—Abacavir—acquired immunodeficiency syndrome	0.000373	0.00174	CcSEcCtD
Fingolimod—Palpitations—Indinavir—acquired immunodeficiency syndrome	0.000372	0.00174	CcSEcCtD
Fingolimod—CYP4F2—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000371	0.00337	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CCL4—acquired immunodeficiency syndrome	0.000369	0.00334	CbGpPWpGaD
Fingolimod—Back pain—Delavirdine—acquired immunodeficiency syndrome	0.000368	0.00172	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Nelfinavir—acquired immunodeficiency syndrome	0.000368	0.00172	CcSEcCtD
Fingolimod—Diarrhoea—Amprenavir—acquired immunodeficiency syndrome	0.000367	0.00172	CcSEcCtD
Fingolimod—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000367	0.00284	CbGeAlD
Fingolimod—Cough—Indinavir—acquired immunodeficiency syndrome	0.000367	0.00172	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Stavudine—acquired immunodeficiency syndrome	0.000367	0.00171	CcSEcCtD
Fingolimod—Angiopathy—Ritonavir—acquired immunodeficiency syndrome	0.000367	0.00171	CcSEcCtD
Fingolimod—Fatigue—Stavudine—acquired immunodeficiency syndrome	0.000366	0.00171	CcSEcCtD
Fingolimod—Connective tissue disorder—Lamivudine—acquired immunodeficiency syndrome	0.000365	0.0017	CcSEcCtD
Fingolimod—Mediastinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000364	0.0017	CcSEcCtD
Fingolimod—S1PR4—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000363	0.00329	CbGpPWpGaD
Fingolimod—Eye disorder—Saquinavir—acquired immunodeficiency syndrome	0.000363	0.0017	CcSEcCtD
Fingolimod—Nervous system disorder—Zidovudine—acquired immunodeficiency syndrome	0.000362	0.00169	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Abacavir—acquired immunodeficiency syndrome	0.000361	0.00169	CcSEcCtD
Fingolimod—Cardiac disorder—Saquinavir—acquired immunodeficiency syndrome	0.000361	0.00169	CcSEcCtD
Fingolimod—Fatigue—Abacavir—acquired immunodeficiency syndrome	0.000361	0.00169	CcSEcCtD
Fingolimod—Skin disorder—Zidovudine—acquired immunodeficiency syndrome	0.000359	0.00168	CcSEcCtD
Fingolimod—Vision blurred—Delavirdine—acquired immunodeficiency syndrome	0.000358	0.00168	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Indinavir—acquired immunodeficiency syndrome	0.000356	0.00166	CcSEcCtD
Fingolimod—Mental disorder—Ritonavir—acquired immunodeficiency syndrome	0.000354	0.00165	CcSEcCtD
Fingolimod—Angiopathy—Saquinavir—acquired immunodeficiency syndrome	0.000353	0.00165	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—CCL3L1—acquired immunodeficiency syndrome	0.000352	0.00319	CbGpPWpGaD
Fingolimod—Palpitations—Efavirenz—acquired immunodeficiency syndrome	0.000351	0.00164	CcSEcCtD
Fingolimod—Asthenia—Didanosine—acquired immunodeficiency syndrome	0.000351	0.00164	CcSEcCtD
Fingolimod—Mediastinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.00035	0.00164	CcSEcCtD
Fingolimod—S1PR3—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00035	0.00317	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.00035	0.00317	CbGpPWpGaD
Fingolimod—Cough—Efavirenz—acquired immunodeficiency syndrome	0.000347	0.00162	CcSEcCtD
Fingolimod—Pruritus—Didanosine—acquired immunodeficiency syndrome	0.000346	0.00162	CcSEcCtD
Fingolimod—Alopecia—Saquinavir—acquired immunodeficiency syndrome	0.000344	0.00161	CcSEcCtD
Fingolimod—Hypertension—Efavirenz—acquired immunodeficiency syndrome	0.000343	0.0016	CcSEcCtD
Fingolimod—Mental disorder—Saquinavir—acquired immunodeficiency syndrome	0.000341	0.00159	CcSEcCtD
Fingolimod—Leukopenia—Delavirdine—acquired immunodeficiency syndrome	0.00034	0.00159	CcSEcCtD
Fingolimod—Back pain—Ritonavir—acquired immunodeficiency syndrome	0.00034	0.00159	CcSEcCtD
Fingolimod—Nervous system disorder—Indinavir—acquired immunodeficiency syndrome	0.000337	0.00157	CcSEcCtD
Fingolimod—Headache—Amprenavir—acquired immunodeficiency syndrome	0.000336	0.00157	CcSEcCtD
Fingolimod—Palpitations—Delavirdine—acquired immunodeficiency syndrome	0.000336	0.00157	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Efavirenz—acquired immunodeficiency syndrome	0.000336	0.00157	CcSEcCtD
Fingolimod—Diarrhoea—Didanosine—acquired immunodeficiency syndrome	0.000335	0.00156	CcSEcCtD
Fingolimod—Mediastinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000334	0.00156	CcSEcCtD
Fingolimod—CYP2E1—lung—acquired immunodeficiency syndrome	0.000334	0.00258	CbGeAlD
Fingolimod—Skin disorder—Indinavir—acquired immunodeficiency syndrome	0.000333	0.00156	CcSEcCtD
Fingolimod—Cough—Delavirdine—acquired immunodeficiency syndrome	0.000332	0.00155	CcSEcCtD
Fingolimod—Paraesthesia—Zidovudine—acquired immunodeficiency syndrome	0.000331	0.00155	CcSEcCtD
Fingolimod—Vision blurred—Ritonavir—acquired immunodeficiency syndrome	0.000331	0.00155	CcSEcCtD
Fingolimod—Dyspnoea—Zidovudine—acquired immunodeficiency syndrome	0.000329	0.00154	CcSEcCtD
Fingolimod—Hypertension—Delavirdine—acquired immunodeficiency syndrome	0.000328	0.00153	CcSEcCtD
Fingolimod—Alopecia—Lamivudine—acquired immunodeficiency syndrome	0.000328	0.00153	CcSEcCtD
Fingolimod—S1PR4—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000327	0.00297	CbGpPWpGaD
Fingolimod—Back pain—Saquinavir—acquired immunodeficiency syndrome	0.000327	0.00153	CcSEcCtD
Fingolimod—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000322	0.00249	CbGeAlD
Fingolimod—SPHK1—Metabolism—AGPS—acquired immunodeficiency syndrome	0.000319	0.00289	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Zidovudine—acquired immunodeficiency syndrome	0.000319	0.00149	CcSEcCtD
Fingolimod—Fatigue—Zidovudine—acquired immunodeficiency syndrome	0.000318	0.00149	CcSEcCtD
Fingolimod—Nervous system disorder—Efavirenz—acquired immunodeficiency syndrome	0.000318	0.00149	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—CCL5—acquired immunodeficiency syndrome	0.000318	0.00288	CbGpPWpGaD
Fingolimod—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000317	0.00245	CbGeAlD
Fingolimod—Asthenia—Nevirapine—acquired immunodeficiency syndrome	0.000316	0.00148	CcSEcCtD
Fingolimod—S1PR3—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000315	0.00286	CbGpPWpGaD
Fingolimod—S1PR5—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000315	0.00286	CbGpPWpGaD
Fingolimod—Skin disorder—Efavirenz—acquired immunodeficiency syndrome	0.000315	0.00147	CcSEcCtD
Fingolimod—Leukopenia—Ritonavir—acquired immunodeficiency syndrome	0.000315	0.00147	CcSEcCtD
Fingolimod—Back pain—Lamivudine—acquired immunodeficiency syndrome	0.000312	0.00146	CcSEcCtD
Fingolimod—Pruritus—Nevirapine—acquired immunodeficiency syndrome	0.000311	0.00145	CcSEcCtD
Fingolimod—Palpitations—Ritonavir—acquired immunodeficiency syndrome	0.000311	0.00145	CcSEcCtD
Fingolimod—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000309	0.00239	CbGeAlD
Fingolimod—Infection—Delavirdine—acquired immunodeficiency syndrome	0.000308	0.00144	CcSEcCtD
Fingolimod—Paraesthesia—Indinavir—acquired immunodeficiency syndrome	0.000308	0.00144	CcSEcCtD
Fingolimod—Cough—Ritonavir—acquired immunodeficiency syndrome	0.000307	0.00143	CcSEcCtD
Fingolimod—CYP3A4—blood—acquired immunodeficiency syndrome	0.000307	0.00237	CbGeAlD
Fingolimod—Headache—Didanosine—acquired immunodeficiency syndrome	0.000306	0.00143	CcSEcCtD
Fingolimod—Dyspnoea—Indinavir—acquired immunodeficiency syndrome	0.000306	0.00143	CcSEcCtD
Fingolimod—Asthenia—Nelfinavir—acquired immunodeficiency syndrome	0.000306	0.00143	CcSEcCtD
Fingolimod—Asthenia—Stavudine—acquired immunodeficiency syndrome	0.000305	0.00142	CcSEcCtD
Fingolimod—Hypertension—Ritonavir—acquired immunodeficiency syndrome	0.000304	0.00142	CcSEcCtD
Fingolimod—Leukopenia—Saquinavir—acquired immunodeficiency syndrome	0.000303	0.00142	CcSEcCtD
Fingolimod—CYP2D6—blood—acquired immunodeficiency syndrome	0.000302	0.00233	CbGeAlD
Fingolimod—Skin disorder—Delavirdine—acquired immunodeficiency syndrome	0.000301	0.00141	CcSEcCtD
Fingolimod—Pruritus—Nelfinavir—acquired immunodeficiency syndrome	0.000301	0.00141	CcSEcCtD
Fingolimod—Diarrhoea—Nevirapine—acquired immunodeficiency syndrome	0.000301	0.00141	CcSEcCtD
Fingolimod—Pruritus—Stavudine—acquired immunodeficiency syndrome	0.000301	0.0014	CcSEcCtD
Fingolimod—Asthenia—Abacavir—acquired immunodeficiency syndrome	0.0003	0.0014	CcSEcCtD
Fingolimod—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000298	0.0023	CbGeAlD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Ritonavir—acquired immunodeficiency syndrome	0.000297	0.00139	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Indinavir—acquired immunodeficiency syndrome	0.000296	0.00139	CcSEcCtD
Fingolimod—Pruritus—Abacavir—acquired immunodeficiency syndrome	0.000296	0.00138	CcSEcCtD
Fingolimod—Fatigue—Indinavir—acquired immunodeficiency syndrome	0.000296	0.00138	CcSEcCtD
Fingolimod—Cough—Saquinavir—acquired immunodeficiency syndrome	0.000295	0.00138	CcSEcCtD
Fingolimod—Hypertension—Saquinavir—acquired immunodeficiency syndrome	0.000292	0.00137	CcSEcCtD
Fingolimod—Diarrhoea—Nelfinavir—acquired immunodeficiency syndrome	0.000292	0.00136	CcSEcCtD
Fingolimod—Paraesthesia—Efavirenz—acquired immunodeficiency syndrome	0.000291	0.00136	CcSEcCtD
Fingolimod—Diarrhoea—Stavudine—acquired immunodeficiency syndrome	0.000291	0.00136	CcSEcCtD
Fingolimod—Hypotension—Delavirdine—acquired immunodeficiency syndrome	0.00029	0.00136	CcSEcCtD
Fingolimod—Dyspnoea—Efavirenz—acquired immunodeficiency syndrome	0.000289	0.00135	CcSEcCtD
Fingolimod—Leukopenia—Lamivudine—acquired immunodeficiency syndrome	0.000289	0.00135	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000288	0.00261	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000287	0.0026	CbGpPWpGaD
Fingolimod—Diarrhoea—Abacavir—acquired immunodeficiency syndrome	0.000286	0.00134	CcSEcCtD
Fingolimod—S1PR1—GPCR ligand binding—CCR5—acquired immunodeficiency syndrome	0.000286	0.00259	CbGpPWpGaD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Saquinavir—acquired immunodeficiency syndrome	0.000286	0.00134	CcSEcCtD
Fingolimod—Cough—Lamivudine—acquired immunodeficiency syndrome	0.000282	0.00132	CcSEcCtD
Fingolimod—Dizziness—Nelfinavir—acquired immunodeficiency syndrome	0.000282	0.00132	CcSEcCtD
Fingolimod—Nervous system disorder—Ritonavir—acquired immunodeficiency syndrome	0.000281	0.00132	CcSEcCtD
Fingolimod—Dizziness—Stavudine—acquired immunodeficiency syndrome	0.000281	0.00131	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Efavirenz—acquired immunodeficiency syndrome	0.00028	0.00131	CcSEcCtD
Fingolimod—Fatigue—Efavirenz—acquired immunodeficiency syndrome	0.00028	0.00131	CcSEcCtD
Fingolimod—Skin disorder—Ritonavir—acquired immunodeficiency syndrome	0.000279	0.0013	CcSEcCtD
Fingolimod—Paraesthesia—Delavirdine—acquired immunodeficiency syndrome	0.000279	0.0013	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000278	0.00252	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000278	0.00252	CbGpPWpGaD
Fingolimod—Dyspnoea—Delavirdine—acquired immunodeficiency syndrome	0.000277	0.00129	CcSEcCtD
Fingolimod—Dizziness—Abacavir—acquired immunodeficiency syndrome	0.000277	0.00129	CcSEcCtD
Fingolimod—S1PR3—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000276	0.0025	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000276	0.0025	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000276	0.0025	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000276	0.0025	CbGpPWpGaD
Fingolimod—Headache—Nevirapine—acquired immunodeficiency syndrome	0.000276	0.00129	CcSEcCtD
Fingolimod—Infection—Saquinavir—acquired immunodeficiency syndrome	0.000274	0.00128	CcSEcCtD
Fingolimod—Unspecified disorder of skin and subcutaneous tissue—Lamivudine—acquired immunodeficiency syndrome	0.000273	0.00128	CcSEcCtD
Fingolimod—Nervous system disorder—Saquinavir—acquired immunodeficiency syndrome	0.000271	0.00127	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00027	0.00245	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00027	0.00245	CbGpPWpGaD
Fingolimod—Skin disorder—Saquinavir—acquired immunodeficiency syndrome	0.000268	0.00125	CcSEcCtD
Fingolimod—Hypotension—Ritonavir—acquired immunodeficiency syndrome	0.000268	0.00125	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Delavirdine—acquired immunodeficiency syndrome	0.000268	0.00125	CcSEcCtD
Fingolimod—Fatigue—Delavirdine—acquired immunodeficiency syndrome	0.000268	0.00125	CcSEcCtD
Fingolimod—Headache—Nelfinavir—acquired immunodeficiency syndrome	0.000267	0.00125	CcSEcCtD
Fingolimod—SPHK1—VEGFA-VEGFR2 Pathway—IL6—acquired immunodeficiency syndrome	0.000267	0.00242	CbGpPWpGaD
Fingolimod—Headache—Stavudine—acquired immunodeficiency syndrome	0.000266	0.00124	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000265	0.0024	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000265	0.0024	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000265	0.0024	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000265	0.0024	CbGpPWpGaD
Fingolimod—Asthenia—Zidovudine—acquired immunodeficiency syndrome	0.000265	0.00124	CcSEcCtD
Fingolimod—Headache—Abacavir—acquired immunodeficiency syndrome	0.000262	0.00123	CcSEcCtD
Fingolimod—Infection—Lamivudine—acquired immunodeficiency syndrome	0.000262	0.00122	CcSEcCtD
Fingolimod—Pruritus—Zidovudine—acquired immunodeficiency syndrome	0.000261	0.00122	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000261	0.00236	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00026	0.00236	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.00026	0.00236	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00026	0.00236	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.00026	0.00236	CbGpPWpGaD
Fingolimod—Nervous system disorder—Lamivudine—acquired immunodeficiency syndrome	0.000258	0.00121	CcSEcCtD
Fingolimod—Hypotension—Saquinavir—acquired immunodeficiency syndrome	0.000258	0.00121	CcSEcCtD
Fingolimod—Paraesthesia—Ritonavir—acquired immunodeficiency syndrome	0.000258	0.0012	CcSEcCtD
Fingolimod—Skin disorder—Lamivudine—acquired immunodeficiency syndrome	0.000256	0.0012	CcSEcCtD
Fingolimod—Dyspnoea—Ritonavir—acquired immunodeficiency syndrome	0.000256	0.0012	CcSEcCtD
Fingolimod—Diarrhoea—Zidovudine—acquired immunodeficiency syndrome	0.000253	0.00118	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CCL3—acquired immunodeficiency syndrome	0.000252	0.00228	CbGpPWpGaD
Fingolimod—SPHK1—Signaling by VEGF—IL6—acquired immunodeficiency syndrome	0.000252	0.00228	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000251	0.00227	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000251	0.00227	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CCR2—acquired immunodeficiency syndrome	0.000251	0.00227	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000249	0.00226	CbGpPWpGaD
Fingolimod—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000249	0.00192	CbGeAlD
Fingolimod—Paraesthesia—Saquinavir—acquired immunodeficiency syndrome	0.000248	0.00116	CcSEcCtD
Fingolimod—Gastrointestinal disorder—Ritonavir—acquired immunodeficiency syndrome	0.000248	0.00116	CcSEcCtD
Fingolimod—Fatigue—Ritonavir—acquired immunodeficiency syndrome	0.000247	0.00116	CcSEcCtD
Fingolimod—Asthenia—Indinavir—acquired immunodeficiency syndrome	0.000246	0.00115	CcSEcCtD
Fingolimod—Dyspnoea—Saquinavir—acquired immunodeficiency syndrome	0.000246	0.00115	CcSEcCtD
Fingolimod—Hypotension—Lamivudine—acquired immunodeficiency syndrome	0.000246	0.00115	CcSEcCtD
Fingolimod—S1PR4—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000245	0.00222	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000245	0.00222	CbGpPWpGaD
Fingolimod—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000245	0.00189	CbGeAlD
Fingolimod—Dizziness—Zidovudine—acquired immunodeficiency syndrome	0.000244	0.00114	CcSEcCtD
Fingolimod—Pruritus—Indinavir—acquired immunodeficiency syndrome	0.000243	0.00114	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000241	0.00218	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000241	0.00218	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00024	0.00217	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.00024	0.00217	CbGpPWpGaD
Fingolimod—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.00024	0.00185	CbGeAlD
Fingolimod—Gastrointestinal disorder—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00111	CcSEcCtD
Fingolimod—Fatigue—Saquinavir—acquired immunodeficiency syndrome	0.000238	0.00111	CcSEcCtD
Fingolimod—Paraesthesia—Lamivudine—acquired immunodeficiency syndrome	0.000237	0.00111	CcSEcCtD
Fingolimod—CYP2E1—brain—acquired immunodeficiency syndrome	0.000236	0.00183	CbGeAlD
Fingolimod—S1PR5—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000236	0.00214	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000236	0.00214	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000236	0.00214	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000236	0.00214	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCR4—acquired immunodeficiency syndrome	0.000236	0.00214	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CXCL12—acquired immunodeficiency syndrome	0.000236	0.00214	CbGpPWpGaD
Fingolimod—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000236	0.00182	CbGeAlD
Fingolimod—Dyspnoea—Lamivudine—acquired immunodeficiency syndrome	0.000235	0.0011	CcSEcCtD
Fingolimod—Diarrhoea—Indinavir—acquired immunodeficiency syndrome	0.000235	0.0011	CcSEcCtD
Fingolimod—Asthenia—Efavirenz—acquired immunodeficiency syndrome	0.000233	0.00109	CcSEcCtD
Fingolimod—Headache—Zidovudine—acquired immunodeficiency syndrome	0.000231	0.00108	CcSEcCtD
Fingolimod—Pruritus—Efavirenz—acquired immunodeficiency syndrome	0.00023	0.00107	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CCR2—acquired immunodeficiency syndrome	0.000228	0.00207	CbGpPWpGaD
Fingolimod—Gastrointestinal disorder—Lamivudine—acquired immunodeficiency syndrome	0.000228	0.00106	CcSEcCtD
Fingolimod—Fatigue—Lamivudine—acquired immunodeficiency syndrome	0.000227	0.00106	CcSEcCtD
Fingolimod—Dizziness—Indinavir—acquired immunodeficiency syndrome	0.000227	0.00106	CcSEcCtD
Fingolimod—Asthenia—Delavirdine—acquired immunodeficiency syndrome	0.000223	0.00104	CcSEcCtD
Fingolimod—Diarrhoea—Efavirenz—acquired immunodeficiency syndrome	0.000222	0.00104	CcSEcCtD
Fingolimod—Pruritus—Delavirdine—acquired immunodeficiency syndrome	0.00022	0.00103	CcSEcCtD
Fingolimod—S1PR1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000218	0.00197	CbGpPWpGaD
Fingolimod—Headache—Indinavir—acquired immunodeficiency syndrome	0.000215	0.00101	CcSEcCtD
Fingolimod—Dizziness—Efavirenz—acquired immunodeficiency syndrome	0.000215	0.001	CcSEcCtD
Fingolimod—S1PR1—Signaling by GPCR—CXCR4—acquired immunodeficiency syndrome	0.000214	0.00194	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CXCL12—acquired immunodeficiency syndrome	0.000214	0.00194	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCNT1—acquired immunodeficiency syndrome	0.000213	0.00193	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—ACKR1—acquired immunodeficiency syndrome	0.000213	0.00193	CbGpPWpGaD
Fingolimod—Diarrhoea—Delavirdine—acquired immunodeficiency syndrome	0.000212	0.000993	CcSEcCtD
Fingolimod—Asthenia—Ritonavir—acquired immunodeficiency syndrome	0.000206	0.000962	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000205	0.00186	CbGpPWpGaD
Fingolimod—Dizziness—Delavirdine—acquired immunodeficiency syndrome	0.000205	0.000959	CcSEcCtD
Fingolimod—Headache—Efavirenz—acquired immunodeficiency syndrome	0.000203	0.00095	CcSEcCtD
Fingolimod—Pruritus—Ritonavir—acquired immunodeficiency syndrome	0.000203	0.000949	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000202	0.00183	CbGpPWpGaD
Fingolimod—Asthenia—Saquinavir—acquired immunodeficiency syndrome	0.000198	0.000926	CcSEcCtD
Fingolimod—S1PR5—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000198	0.00179	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.000198	0.00179	CbGpPWpGaD
Fingolimod—Diarrhoea—Ritonavir—acquired immunodeficiency syndrome	0.000196	0.000918	CcSEcCtD
Fingolimod—Pruritus—Saquinavir—acquired immunodeficiency syndrome	0.000195	0.000913	CcSEcCtD
Fingolimod—S1PR5—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000195	0.00176	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000195	0.00176	CbGpPWpGaD
Fingolimod—Headache—Delavirdine—acquired immunodeficiency syndrome	0.000194	0.000909	CcSEcCtD
Fingolimod—SPHK1—Signaling Pathways—CCL4—acquired immunodeficiency syndrome	0.000193	0.00175	CbGpPWpGaD
Fingolimod—Dizziness—Ritonavir—acquired immunodeficiency syndrome	0.00019	0.000887	CcSEcCtD
Fingolimod—Asthenia—Lamivudine—acquired immunodeficiency syndrome	0.000189	0.000884	CcSEcCtD
Fingolimod—Diarrhoea—Saquinavir—acquired immunodeficiency syndrome	0.000189	0.000883	CcSEcCtD
Fingolimod—CYP2D6—brain—acquired immunodeficiency syndrome	0.000187	0.00145	CbGeAlD
Fingolimod—S1PR4—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000187	0.00169	CbGpPWpGaD
Fingolimod—Pruritus—Lamivudine—acquired immunodeficiency syndrome	0.000186	0.000871	CcSEcCtD
Fingolimod—S1PR4—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000185	0.00168	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000184	0.00166	CbGpPWpGaD
Fingolimod—Dizziness—Saquinavir—acquired immunodeficiency syndrome	0.000183	0.000854	CcSEcCtD
Fingolimod—Diarrhoea—Lamivudine—acquired immunodeficiency syndrome	0.00018	0.000843	CcSEcCtD
Fingolimod—Headache—Ritonavir—acquired immunodeficiency syndrome	0.00018	0.00084	CcSEcCtD
Fingolimod—S1PR3—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00018	0.00163	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.00018	0.00163	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CCL5—acquired immunodeficiency syndrome	0.00018	0.00163	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000178	0.00161	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000178	0.00161	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000177	0.0016	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000177	0.0016	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CSF2—acquired immunodeficiency syndrome	0.000177	0.0016	CbGpPWpGaD
Fingolimod—Dizziness—Lamivudine—acquired immunodeficiency syndrome	0.000174	0.000815	CcSEcCtD
Fingolimod—Headache—Saquinavir—acquired immunodeficiency syndrome	0.000173	0.000809	CcSEcCtD
Fingolimod—CYP4F2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000171	0.00155	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.00017	0.00154	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000168	0.00152	CbGpPWpGaD
Fingolimod—Headache—Lamivudine—acquired immunodeficiency syndrome	0.000165	0.000772	CcSEcCtD
Fingolimod—S1PR5—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000164	0.00149	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000164	0.00149	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	0.000163	0.00148	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000162	0.00147	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000162	0.00147	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	0.000162	0.00147	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	0.000161	0.00146	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000154	0.0014	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000149	0.00135	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000148	0.00134	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000148	0.00134	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	0.000147	0.00133	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	0.000147	0.00133	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000145	0.00131	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000145	0.00131	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000139	0.00126	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000139	0.00126	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000139	0.00126	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000139	0.00126	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000135	0.00122	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	0.000132	0.00119	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000127	0.00115	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000127	0.00115	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	0.000119	0.00108	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	0.000112	0.00102	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	0.000112	0.00102	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.00011	0.000998	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000109	0.000984	CbGpPWpGaD
Fingolimod—S1PR4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000107	0.000969	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000106	0.000961	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	0.000106	0.000961	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000104	0.000947	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	0.000104	0.000947	CbGpPWpGaD
Fingolimod—S1PR5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000103	0.000933	CbGpPWpGaD
Fingolimod—S1PR3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	0.000103	0.000933	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.93e-05	0.0009	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.71e-05	0.00088	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.63e-05	0.000873	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.56e-05	0.000866	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.56e-05	0.000866	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.49e-05	0.00086	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.35e-05	0.000847	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.35e-05	0.000847	CbGpPWpGaD
Fingolimod—S1PR1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.35e-05	0.000847	CbGpPWpGaD
Fingolimod—CYP4F12—Metabolism—ALB—acquired immunodeficiency syndrome	8.82e-05	0.0008	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.68e-05	0.000786	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.52e-05	0.000772	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.49e-05	0.000769	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.4e-05	0.000761	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.68e-05	0.000696	CbGpPWpGaD
Fingolimod—CYP4F2—Metabolism—ALB—acquired immunodeficiency syndrome	7.62e-05	0.00069	CbGpPWpGaD
Fingolimod—SPHK1—Metabolism—ALB—acquired immunodeficiency syndrome	6.54e-05	0.000593	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—TAT—acquired immunodeficiency syndrome	6.16e-05	0.000558	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.74e-05	0.00052	CbGpPWpGaD
Fingolimod—S1PR4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.71e-05	0.000517	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.52e-05	0.0005	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.52e-05	0.0005	CbGpPWpGaD
Fingolimod—S1PR3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.49e-05	0.000498	CbGpPWpGaD
Fingolimod—S1PR5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.49e-05	0.000498	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—AGPS—acquired immunodeficiency syndrome	5.24e-05	0.000475	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.01e-05	0.000454	CbGpPWpGaD
Fingolimod—S1PR1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.99e-05	0.000452	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.44e-05	0.000402	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—TAT—acquired immunodeficiency syndrome	4.37e-05	0.000396	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—AGPS—acquired immunodeficiency syndrome	3.72e-05	0.000337	CbGpPWpGaD
Fingolimod—S1PR4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.37e-05	0.000305	CbGpPWpGaD
Fingolimod—S1PR5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.25e-05	0.000294	CbGpPWpGaD
Fingolimod—S1PR3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.25e-05	0.000294	CbGpPWpGaD
Fingolimod—S1PR1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.95e-05	0.000267	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—TAT—acquired immunodeficiency syndrome	2.86e-05	0.000259	CbGpPWpGaD
Fingolimod—SPHK1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.61e-05	0.000236	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	2.43e-05	0.00022	CbGpPWpGaD
Fingolimod—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	1.07e-05	9.73e-05	CbGpPWpGaD
Fingolimod—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	7.62e-06	6.91e-05	CbGpPWpGaD
Fingolimod—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	4.98e-06	4.52e-05	CbGpPWpGaD
